145 phase 3 GLP-1 trials are recruiting or underway

Short answer

On November 13, 2026, the ClinicalTrials.gov registry carried 145 phase 3 trials of GLP-1 medications that were recruiting, active but not recruiting, or not yet recruiting. Across all statuses, the registry carried 564 GLP-1 trials. The 145 breaks down as 71 recruiting, 40 active and not recruiting, and 34 not yet recruiting.

Counted November 13, 2026, from ClinicalTrials.gov.

The 145, by status

Three statuses are counted here, and they add to 145. Each row is one status exactly as the registry states it, with no other figure beside it.

Recruiting

71 trials

Active, not recruiting

40 trials

Not yet recruiting

34 trials

Phase 3 trials in those three statuses

145 trials

The registry as a whole carried 564 GLP-1 trials across all statuses on the same day. The 145 sits inside that larger number; it is the slice that is either running or about to run.

What phase 3 means

Phase 3 is the large stage of testing that comes before a maker can ask the FDA to approve a new drug or a new use of one. It is where a candidate is studied at scale, in the form and dose that would be marketed, so the results can be submitted in support of an application.

In plain terms: a phase 3 trial is a question being asked at size. The answer is not known when the trial is registered, and registering it does not decide what the answer will be.

A running trial is not a promise

A running trial is not a promise that any product will be approved or sold. A count of trials is a count of work in progress. It says how much testing is under way, not how that testing will end, and not whether anything will reach a pharmacy shelf.

That is why this page reports the count and the status names without naming any experimental drug or company, and without a date on which something is expected to be approved. None of those can be read off a registry count.

Compounded medications are not FDA-approved

Compounded semaglutide and compounded tirzepatide are not FDA-approved. A pipeline of phase 3 trials does not change that today, and no trial count on this page should be read as approval of any compounded preparation.

Why this guide tracks cash prices

This guide records what programs charge in cash for the compounded medications sold now, and dates every figure it records. A trial count is noted as a trial count; it is never used here as a price, a forecast, or evidence about an outcome. To see the programs themselves, start with the buyer guide; to see how each charge is read, dated and compared, read how we compare.